SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brad C. Dunlap who wrote (837)5/9/1997 10:17:00 PM
From: I. Luttichuys   of 1762
 
Hello Brad, I read the Cephalon situation the same way. The results were known to be somewhat troubling and the stock itself seemed to indicate some apprehension about what the possible FDA action might be as you point out.
IDEC has some rather stellar trials results but, inspite of this, we, along with many biotechs, may have sustained some weakness today as a result of the Cephalon/Chiron news. No one likes to hear about an FDA rejection... that's for sure.
Howard, if you are reading this, welcome to the thread and, although it will seem a chore, might I suggest you read through the thread. There is alot of valuable info here.
BENNETT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News